Similarly, ultra-rare deleterious variants in the extracellular matrix genes FRAS1-related extracellular matrix 2 (FREM2) and perlecan (HSPG2) were found to be associated with myelomeningocele in a cohort of North American individuals (Au et al., 2021). This evidence concerns the gene FREM2 and myelomeningocele.